Meliconi R, Parracino O, Facchini A, Morselli-Labate A M, Bortolotti F, Tremolada F, Martuzzi M, Miglio F, Gasbarrini G
I Patologia Medica & I Clinica Medica, Università di Bologna, Italy.
Liver. 1988 Apr;8(2):65-74. doi: 10.1111/j.1600-0676.1988.tb00970.x.
Six acute phase proteins (haptoglobin, alpha 1-acid glycoprotein, alpha 1-antitrypsin, alpha 2-macroglobulin, C reactive protein and transferrin) have been measured in the sera of chronic liver disease (CLD) patients with different aetiology (viral, autoimmune and alcoholic) and histology (steatosis, chronic persistent hepatitis, chronic active hepatitis, cirrhosis), and in patients with liver cancer. 1) The most striking changes concerned alpha 2-macroglobulin (increased) and haptoglobin (decreased) levels. 2) Transferrin was lower in alcoholic liver disease than in viral CLD, CRP was lower in autoimmune than in viral or alcoholic CLD, and alpha 1-acid glycoprotein was lower in viral and alcoholic CLD than in autoimmune CLD. Acute phase protein assay may prove useful in differential diagnosis, particularly when specific markers are not available (autoimmune, non A, non B, alcoholic liver diseases). 3) No significant differences related to aetiology (B, non A non B, D viruses) were observed in viral CLD. 4) Patients who progressed to CLD after acute viral hepatitis type B or non A non B did not show different APP levels from those who had recovered when tested 8-12 months after the acute phase. 5) The pattern of APP changes observed in primary liver cell carcinoma was different from both the cirrhotic pattern and the pattern presented by other tumours with or without liver metastasis.
已对不同病因(病毒性、自身免疫性和酒精性)和组织学类型(脂肪变性、慢性持续性肝炎、慢性活动性肝炎、肝硬化)的慢性肝病(CLD)患者以及肝癌患者的血清进行了六种急性期蛋白(触珠蛋白、α1-酸性糖蛋白、α1-抗胰蛋白酶、α2-巨球蛋白、C反应蛋白和转铁蛋白)的检测。1)最显著的变化涉及α2-巨球蛋白水平升高和触珠蛋白水平降低。2)酒精性肝病患者的转铁蛋白水平低于病毒性CLD患者,自身免疫性CLD患者的CRP低于病毒性或酒精性CLD患者,病毒性和酒精性CLD患者的α1-酸性糖蛋白低于自身免疫性CLD患者。急性期蛋白检测可能在鉴别诊断中有用,特别是在没有特异性标志物(自身免疫性、非甲非乙型、酒精性肝病)时。3)在病毒性CLD中,未观察到与病因(B型、非甲非乙型、D型病毒)相关的显著差异。4)急性乙型或非甲非乙型病毒性肝炎后进展为CLD的患者,在急性期后8 - 12个月进行检测时,其急性期蛋白水平与已康复患者无差异。5)原发性肝细胞癌中观察到的急性期蛋白变化模式与肝硬化模式以及有或无肝转移的其他肿瘤所呈现的模式均不同。